Diabetes medication metformin could lower long COVID risk by 41%, study suggests
New Scientist - 09-Jun-2023Metformin may function as an anti-inflammatory and potentially reduce the viral load of SARS-CoV-2
Join the club for FREE to access the whole archive and other member benefits.
Journal providing information about infectious diseases.
The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.
The Lancet Infectious Diseases has an Impact Factor of 27·516® and ranks first among infectious diseases journals (2018 Journal Citation Reports®, Clarivate Analytics 2019). The Lancet Infectious Diseases is recognised for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering such areas as the treatment and research of HIV/AIDS, antibiotic resistance, emerging infections, and public health.
Visit website: https://www.thelancet.com/laninf/about
See also: The Lancet - Medical journal covering general medicine
Details last updated 23-Nov-2019
Metformin may function as an anti-inflammatory and potentially reduce the viral load of SARS-CoV-2
Superbugs are on the rise and we are running out of time
Common infections would kill once again, surgery and cancer therapies under threat. Bacteria fou...